$ARTL
ARTELO BIOSCIENCES, INC.

2021 Q3 Form 10-Q Financial Statement

#000164033421001528 Filed on July 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q2 2020 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.271M $690.0K $660.0K
YoY Change 67.29% -9.21% 144.44%
% of Gross Profit
Research & Development $615.5K $265.2K $721.3K
YoY Change 127.95% 43.97% 47.21%
% of Gross Profit
Depreciation & Amortization $124.00 $124.00
YoY Change -48.97%
% of Gross Profit
Operating Expenses $1.887M $951.4K $1.371M
YoY Change 83.19% 1.07% 80.33%
Operating Profit -$2.245M -$951.4K -$1.371M
YoY Change 1.07%
Interest Expense -$320.00 $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $540.00 $204.00 $408.00
YoY Change -99.97%
Pretax Income -$1.887M -$950.0K -$1.370M
YoY Change 83.17% 179.41% 226.19%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.887M -$951.2K -$1.370M
YoY Change 83.17% 175.8% 222.54%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.162M -$273.8K -$399.4K
COMMON SHARES
Basic Shares Outstanding 24.49M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.07M $1.280M $1.980M
YoY Change 369.89% 341.38% 330.43%
Cash & Equivalents $6.629M $1.279M $1.983M
Short-Term Investments $3.436M
Other Short-Term Assets $252.0K $170.0K $100.0K
YoY Change 26.0% -80.23% 400.0%
Inventory
Prepaid Expenses $252.0K $74.66K
Receivables
Other Receivables
Total Short-Term Assets $10.32M $1.453M $2.110M
YoY Change 341.46% 26.32% 339.58%
LONG-TERM ASSETS
Property, Plant & Equipment $90.00K $1.484K $0.00
YoY Change 36485.37%
Goodwill
YoY Change
Intangibles $2.039M $2.039M
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets $189.0K
YoY Change
Total Long-Term Assets $2.318M $2.041M $2.040M
YoY Change 13.68%
TOTAL ASSETS
Total Short-Term Assets $10.32M $1.453M $2.110M
Total Long-Term Assets $2.318M $2.041M $2.040M
Total Assets $12.64M $3.494M $4.150M
YoY Change 188.73% 203.78% 764.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $493.0K $260.0K $430.0K
YoY Change 0.61% -71.43% -27.12%
Accrued Expenses $28.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $526.0K $268.5K $440.0K
YoY Change 4.99% -73.68% -62.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $67.00K
YoY Change
Total Long-Term Liabilities $67.00K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $526.0K $268.5K $440.0K
Total Long-Term Liabilities $67.00K $0.00 $0.00
Total Liabilities $593.0K $270.0K $440.0K
YoY Change 18.36% -73.53% -62.71%
SHAREHOLDERS EQUITY
Retained Earnings -$16.90M -$8.438M
YoY Change 78.57%
Common Stock $25.00K $3.734K
YoY Change 400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.04M $3.225M $3.708M
YoY Change
Total Liabilities & Shareholders Equity $12.64M $3.494M $4.150M
YoY Change 188.73% 203.78% 764.58%

Cashflow Statement

Concept 2021 Q3 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$1.887M -$951.2K -$1.370M
YoY Change 83.17% 175.8% 222.54%
Depreciation, Depletion And Amortization $124.00 $124.00
YoY Change -48.97%
Cash From Operating Activities -$1.541M -$1.020M -$1.400M
YoY Change 75.15% 72.88% 89.19%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$3.439M
YoY Change
Cash From Investing Activities -$3.439M $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.597M 280.0K 0.000
YoY Change -6.62% -33.33% -100.0%
NET CHANGE
Cash From Operating Activities -1.541M -1.020M -1.400M
Cash From Investing Activities -3.439M 0.000 0.000
Cash From Financing Activities 1.597M 280.0K 0.000
Net Change In Cash -3.384M -740.0K -1.400M
YoY Change -507.66% 335.29% -500.0%
FREE CASH FLOW
Cash From Operating Activities -$1.541M -$1.020M -$1.400M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$1.020M -$1.400M
YoY Change 72.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address Address Line1
EntityAddressAddressLine1
888 Prospect Street
dei Entity Address City Or Town
EntityAddressCityOrTown
La Jolla
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24493982 shares
CY2021Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
72523 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1220924
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
11915820 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
3874685 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9053726 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
12855771 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5461213 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4963364 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3708054 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
3225070 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9419 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1434645 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1865921 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-1306361 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1370126 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16235 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
373 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
16344 USD
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6578553 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
380678 USD
CY2020Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10500 USD
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10500 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
40868 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7614120 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1108090 USD
CY2019Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
539417 USD
CY2019Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
100000 USD
CY2019Q4 artl Adjustments To Additional Paid In Capital Refund For Fractional Stock
AdjustmentsToAdditionalPaidInCapitalRefundForFractionalStock
-117 USD
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10500 USD
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8667 USD
CY2019Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10500 USD
CY2020Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-2500 USD
us-gaap Depreciation
Depreciation
183 USD
us-gaap Depreciation
Depreciation
372 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
330949 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
609691 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
155019 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
97397 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
42482 USD
CY2021Q1 artl Common Shares Value Issued For Exercise Of Warrant
CommonSharesValueIssuedForExerciseOfWarrant
5326144 USD
CY2021Q2 artl Common Shares Value Issued For Exercise Of Warrant
CommonSharesValueIssuedForExerciseOfWarrant
690000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
15151 USD
us-gaap Increase Decrease In Marketable Securities Restricted
IncreaseDecreaseInMarketableSecuritiesRestricted
-2319 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
113866 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12515228 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
270771 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
artl Additional Issuance Of Series D Shares Per Terms Subscription Agreements
AdditionalIssuanceOfSeriesDSharesPerTermsSubscriptionAgreements
7 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 USD
CY2021Q2 artl Common Stock Par Value Before Amendment
CommonStockParValueBeforeAmendment
0.001
CY2021Q2 artl Common Stock Shares Authorized Before Amendment
CommonStockSharesAuthorizedBeforeAmendment
18750000 shares
CY2021Q2 artl Stock Issued During Period Shares Cash
StockIssuedDuringPeriodSharesCash
16000 shares
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.51
CY2021Q2 artl Commission Fee
CommissionFee
23396 USD
CY2021Q2 artl Percentage Of Commission
PercentageOfCommission
0.030 pure
CY2021Q2 artl Offering Costs
OfferingCosts
95919 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2685100 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
artl Stock Issued During Period Value Issued For Services Two
StockIssuedDuringPeriodValueIssuedForServicesTwo
5695329 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2966934 shares
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y6M25D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
265572 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.38
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y6M21D
artl Operating Lease Lease Not Yet Commenced One Year
OperatingLeaseLeaseNotYetCommencedOneYear
32918 USD
artl Operating Lease Lease Not Yet Commenced Within Three Years Three Monthss
OperatingLeaseLeaseNotYetCommencedWithinThreeYearsThreeMonthss
110680 USD

Files In Submission

Name View Source Status
0001640334-21-001528-index-headers.html Edgar Link pending
0001640334-21-001528-index.html Edgar Link pending
0001640334-21-001528.txt Edgar Link pending
0001640334-21-001528-xbrl.zip Edgar Link pending
artl-20210531.xml Edgar Link completed
artl-20210531.xsd Edgar Link pending
artl-20210531_cal.xml Edgar Link unprocessable
artl-20210531_def.xml Edgar Link unprocessable
artl-20210531_lab.xml Edgar Link unprocessable
artl-20210531_pre.xml Edgar Link unprocessable
artl_10q.htm Edgar Link pending
artl_ex311.htm Edgar Link pending
artl_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending